Efficacy of sonidegib in patients with aggressive and nonaggressive subtypes of locally advanced basal cell carcinoma

被引：0
|
作者：
Lear, John [1 ]
Migden, Michael [2 ]
Guminski, Alexander [3 ]
Gutzmer, Ralf [4 ]
Lewis, Karl [5 ]
Combemale, Patrick [6 ]
Sellami, Dalila [7 ]
Burnett, Patrick [7 ]
Yi, Tingting [7 ]
Dummer, Reinhard [8 ]
机构：
[1] Manchester Royal Infirm, Manchester, Lancs, England
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Royal North Shore Hosp, Sydney, NSW, Australia
[4] Hannover Med Sch, Hannover, Germany
[5] Univ Colorado, Canc Ctr, Aurora, CO USA
[6] Ctr Leon Berard, Lyon, France
[7] Novartis Pharmaceut, E Hanover, NJ USA
[8] Univ Spital Zurich, Zurich, Switzerland
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2016年 / 74卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
3356
引用
收藏
页码：AB197 / AB197
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of sonidegib in patients (pts) with nevoid basal cell carcinoma syndrome (NBCCS)
    Lear, John
    Migden, Michael
    Guminski, Alexander
    Dirix, Luc
    Chang, Anne Lynn S.
    Burnett, Patrick
    Sellami, Dalila
    Gutzmer, Ralf
    Stingl, Georg
    Dummer, Reinhard
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB196 - AB196
  • [42] NUCLEOLAR ORGANIZER REGIONS IN AGGRESSIVE AND NONAGGRESSIVE BASAL-CELL CARCINOMA OF THE SKIN
    DEROSA, G
    STAIBANO, S
    BARRA, E
    ZEPPA, P
    SALVATORE, G
    VETRANI, A
    PALOMBINI, L
    CANCER, 1992, 69 (01) : 123 - 126
  • [43] P53 PROTEIN IN AGGRESSIVE AND NONAGGRESSIVE BASAL-CELL CARCINOMA
    DEROSA, G
    STAIBANO, S
    BARRA, E
    DONOFRIO, V
    SALVATORE, G
    VESSECCHIA, G
    BOSCAINO, A
    JOURNAL OF CUTANEOUS PATHOLOGY, 1993, 20 (05) : 429 - 434
  • [44] Sonidegib for the treatment of advanced basal cell carcinoma in a liver transplant recipient
    Piccerillo, Alfredo
    Cappilli, Simone
    Costantini, Alessio
    Peris, Ketty
    Di Stefani, Alessandro
    JOURNAL OF DERMATOLOGY, 2023, 50 (10): : E323 - E324
  • [45] Effective systemic treatment of advanced periocular basal cell carcinoma with sonidegib
    Alexander C. Rokohl
    Ludwig M. Heindl
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2021, 259 : 3821 - 3822
  • [46] Effective systemic treatment of advanced periocular basal cell carcinoma with sonidegib
    Rokohl, Alexander C.
    Heindl, Ludwig M.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2021, 259 (12) : 3821 - 3822
  • [47] Differential pharmacology and clinical utility of sonidegib in advanced basal cell carcinoma
    Wahid, Mohd
    Jawed, Arshad
    Dar, Sajad Ahmad
    Mandal, Raju K.
    Haque, Shafiul
    ONCOTARGETS AND THERAPY, 2017, 10 : 515 - 520
  • [48] Sonidegib, a novel smoothened inhibitor for the treatment of advanced basal cell carcinoma
    Doan, Hung Q.
    Silapunt, Sirunya
    Migden, Michael R.
    ONCOTARGETS AND THERAPY, 2016, 9 : 5671 - 5678
  • [49] Sonidegib (Odomzo) for Basal Cell Carcinoma
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2016, 58 (1489): : 31 - 32
  • [50] Quality of life in patients with advanced basal cell carcinoma treated with sonidegib (LDE225)
    Migden, Michael
    Lear, John
    Guminski, Alexander
    Yi, Tingting
    Higuchi, Keiko
    Gutzmer, Ralf
    Dummer, Reinhard
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB191 - AB191
12345